Home/Filings/4/0001209191-23-024105
4//SEC Filing

ROCKLAGE SCOTT M 4

Accession 0001209191-23-024105

CIK 0001835567other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 4:51 PM ET

Size

21.4 KB

Accession

0001209191-23-024105

Insider Transaction Report

Form 4
Period: 2023-04-10
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
Schwab Andrew J.
Director10% Owner
Transactions
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh534,855$64,1830 total(indirect: By 5AM Co-Investors IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh12,836,489$1,540,3790 total(indirect: By 5AM Ventures IV, L.P.)
  • Sale

    Class A Common Stock

    2023-04-10$0.12/sh3,172,769$380,732200,000 total(indirect: By 5AM Opportunities I, L.P.)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.11 to $0.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The shares are directly held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
  • [F3]The shares are directly held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
  • [F4]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001219014

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:51 PM ET
Size
21.4 KB